Not applicableLooking for participantsNCT06817174What this trial is testingOvarian Cancer Radiomics Approach in CT Led EvaluationWho this might be right forOvarian Cancer Imperial College Healthcare NHS Trust 168
Large-scale testing (Phase 3)UnknownNCT01654146What this trial is testingICON8: Weekly Chemotherapy in Ovarian CancerWho this might be right forOvarian Cancer Medical Research Council 1,485
Large-scale testing (Phase 3)UnknownNCT00715286What this trial is testingNeoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized StudyWho this might be right forOvarian Carcinoma All India Institute of Medical Sciences 180
Not applicableStudy completedNCT02039388What this trial is testingLavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial CarcinomaWho this might be right forOvarian Epithelial CancerCarcinoma in SituOvarian Cancer Medical University of Vienna 701
Testing effectiveness (Phase 2)Study completedNCT00030446What this trial is testingErlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer NCIC Clinical Trials Group 50
Early research (Phase 1)Ended earlyNCT05215496What this trial is testing[18F]Fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian CancerWho this might be right forEpithelial Ovarian Cancer Lioe-Fee de Geus-Oei, MD PhD 5
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Study completedNCT00093496What this trial is testingGemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity CancerWho this might be right forPrimary Peritoneal Cavity CancerRecurrent Ovarian Epithelial CancerStage III Ovarian Epithelial Cancer+1 more National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT00003449What this trial is testingCombination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian CancerWho this might be right forOvarian Cancer University of Southern California 35
Large-scale testing (Phase 3)UnknownNCT03693248What this trial is testingReduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal CancerWho this might be right forOvarian Cancer Stage IIICOvarian Cancer Stage IVFallopian Tube Cancer+1 more Seoul National University Hospital 298
Not applicableStudy completedNCT04823871What this trial is testingEarly Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex SequencingWho this might be right forOvarian Epithelial CancerCarcinoma in SituOvarian Cancer Paul Speiser, Prof.MD, 406
Testing effectiveness (Phase 2)Study completedNCT00030706What this trial is testingIxabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerWho this might be right forOvarian CancerPeritoneal Cavity Cancer Montefiore Medical Center
Early research (Phase 1)Looking for participantsNCT05877599What this trial is testingNT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationWho this might be right forNon-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more AstraZeneca 45
Testing effectiveness (Phase 2)Study completedNCT00003072What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerWho this might be right forLung CancerNeurotoxicityOvarian Cancer University of California, San Francisco 80
Testing effectiveness (Phase 2)UnknownNCT03827837What this trial is testingFamitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological TumorsWho this might be right forRenal Cell CarcinomaUrothelial CarcinomaCervical Cancer+2 more Jiangsu HengRui Medicine Co., Ltd. 265
Large-scale testing (Phase 3)Active Not RecruitingNCT01081262What this trial is testingCarboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube CancerWho this might be right forBorderline Ovarian Mucinous TumorOvarian Mucinous CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+21 more National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Ended earlyNCT01583686What this trial is testingCAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic CancerWho this might be right forCervical CancerPancreatic CancerOvarian Cancer+2 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00388037What this trial is testingSunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forRecurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer+12 more National Cancer Institute (NCI) 31
Not applicableUnknownNCT02981901What this trial is testingOptimisation of Disease Management in Patients With Epithelial Ovarian Cancer in FranceWho this might be right forOvarian Epithelial Cancer Centre Leon Berard 376
Early research (Phase 1)Study completedNCT00101257What this trial is testingCellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerWho this might be right forOvarian CancerPeritoneal Cavity Cancer Fred Hutchinson Cancer Center 18